REAL-WORLD ECONOMIC OUTCOMES OF FIRST-LINE (1L) IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)

被引：0
作者：
Challagulla, S. [1 ]
Lee, P. [2 ]
Kistler, K. [3 ]
Douyon, L. [3 ]
Lai, D. [2 ]
Iyengar, R. [2 ]
机构：
[1] Pharmacyclics LLC, Fremont, CA USA
[2] Pharmacyclics LLC, Sunnyvale, CA USA
[3] Xcenda, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN101
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
[21]   Characteristics and clinical outcomes among patients receiving either ibrutinib or antiCD20 monotherapy as first-line (1L) treatment for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): A retrospective analysis in community oncology practice. [J].
Vose, Julie ;
He, Jinghua ;
Lu, Xiaoxiao ;
Wu, Linda ;
Ran, Tao ;
Panjabi, Sumeet .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[22]   Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [J].
Jaglowski, Samantha M. ;
Jones, Jeffrey A. ;
Flynn, Joseph M. ;
Andritsos, Leslie A. ;
Maddocks, Kami J. ;
Woyach, Jennifer A. ;
Blum, Kristie A. ;
Greyer, Michael R. ;
Geyer, Susan Michelle ;
Heerema, Nyla A. ;
Lozanski, Gerard ;
Stefanos, Mona ;
Hall, Nathan ;
Nagar, Veena ;
Munneke, Brian ;
West, Jamie-Sue ;
Neuenburg, Jutta K. ;
James, Danelle F. ;
Johnson, Amy J. ;
Byrd, John C. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 :S206-S207
[23]   Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs. chemoimmunotherapy [J].
Wang, Ruibin ;
Ding, Zhijie ;
Lu, Xiaoxiao ;
Mavani, Heena ;
He, Jinghua ;
Qureshi, Zaina P. ;
Pinilla-Ibarz, Javier .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[24]   Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status [J].
Qing Huang ;
Kathleen L. Deering ;
Qing Harshaw ;
Lori A. Leslie .
Advances in Therapy, 2022, 39 :3292-3307
[25]   Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status [J].
Huang, Qing ;
Deering, Kathleen L. ;
Harshaw, Qing ;
Leslie, Lori A. .
ADVANCES IN THERAPY, 2022, 39 (07) :3292-3307
[26]   Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) [J].
Jain, Nitin ;
Keating, Michael J. ;
Thompson, Philip A. ;
Ferrajoli, Alessandra ;
Burger, Jan A. ;
Borthakur, Gautam M. ;
Takahashi, Koichi ;
Estrov, Zeev E. ;
Fowler, Nathan H. ;
Kadia, Tapan M. ;
Konopleva, Marina Y. ;
Alvarado, Yesid ;
Yilmaz, Musa ;
DiNardo, Courtney D. ;
Bose, Prithviraj ;
Ohanian, Maro ;
Pemmaraju, Naveen ;
Jabbour, Elias ;
Sasaki, Koji ;
Kanagal-Shamanna, Rashmi ;
Patel, Keyur ;
Jorgensen, Jeffrey L. ;
Wang, Sa A. ;
Garg, Naveen ;
Wang, Xuemei ;
Sondermann, Katrina ;
Cruz, Nichole ;
Wei, Chongjuan ;
Ayala, Ana ;
Plunkett, William ;
Kantarjian, Hagop M. ;
Gandhi, Varsha ;
Wierda, William G. .
BLOOD, 2019, 134
[27]   Real World Treatment Patterns in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Switching from First Line Ibrutinib to Acalabrutinib [J].
Jacobs, Ryan ;
Wang, Ruibin ;
He, Jinghua ;
Lu, Xiaoxiao ;
Wu, Linda ;
Khan, Wasiulla ;
Qureshi, Zaina P. ;
Levy, Moshe Yair .
BLOOD, 2022, 140 :8017-8018
[28]   A real-world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first-line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States [J].
Mato, Anthony ;
Tang, Boxiong ;
Azmi, Soraya ;
Yang, Keri ;
Han, Yi ;
Zhang, Xiaowei ;
Roeker, Lindsey ;
Wallis, Nicola ;
Stern, Jennifer C. ;
Hedrick, Eric ;
Huang, Jane ;
Sharman, Jeff P. .
EJHAEM, 2023, 4 (01) :135-144
[29]   Real-world understanding of the unmet need for treatment of non-covalent BTKi in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) [J].
Choksi, Rushir J. ;
Hou, Jing-Zhou ;
Li, John ;
Gart, Mike ;
Vasudevan, Anupama ;
Blanc, Simon .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[30]   Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Utilization and Clinical Outcomes Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [J].
Hou, Jing-Zhou ;
Choksi, Rushir ;
Maglinte, Gregory A. ;
Uasudevan, Anupama ;
Rui, Anna ;
Wang, Brandon ;
Pham, Hoa ;
Lasn, Ann ;
Blanc, Simon .
BLOOD, 2024, 144 :2353-2354
12345